Evidence map›Paper›PMID 40407303›Full record

ArticleTissue engineering. Part A2026

Donor Variability and 3D Culture Models Influence Human Mesenchymal Stem Cell Differentiation.

Sarah Jones, Michelle Tai, Manish Ayushman, Abena Peasah, Julia Johannsen, Fan Yang

Abstract read
In one paragraph

Article in Tissue engineering. Part A, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarah JonesDepartment of Chemistry, Stanford University, Stanford, California, USA.ORCID 0000-0002-2382-2328
Michelle TaiDepartment of Bioengineering, Stanford University, Stanford, California, USA.ORCID 0000-0001-9508-9404
Manish AyushmanDepartment of Bioengineering, Stanford University, Stanford, California, USA.
Abena PeasahDepartment of Bioengineering, Stanford University, Stanford, California, USA.
Julia JohannsenDepartment of Biology, Stanford University, Stanford, California, USA.ORCID 0009-0004-4084-7158
Fan YangDepartment of Bioengineering, Stanford University, Stanford, California, USA.

Funding

Microribbon scaffold-mediated Immunomodulation for Cranial Bone RepairR01DE024772 · NIDCR · STANFORD UNIVERSITY · PI YANG, FAN · 2015 to 2025
$4.6M
Sliding hydrogels for accelerating cartilage regenerationR01AR074502 · NIAMS · STANFORD UNIVERSITY · PI YANG, FAN · 2019 to 2023
$2.2M
Cell membrane-coated macroporous scaffolds for enhancing bone regeneration in agingR01AI180049 · NIAID · STANFORD UNIVERSITY · PI Fan Yang · 2024 to 2026
$1.9M
NIAID NIH HHS R01 AI180049NIAMS NIH HHS R01 AR074502NIDCR NIH HHS R01 DE024772
6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are widely used for tissue regeneration due to their multilineage differentiation potential and ability to secrete paracrine factors with immunomodulatory and angiogenic functions. Standard MSC differentiation protocols typically rely on two-dimensional (2D) or pellet culture models that are simple to use but not well-suited for translational or clinical applications. To promote better cell survival, tissue deposition, and differentiation of MSCs, a wide variety of three-dimensional (3D) biomaterial scaffolds and platforms have been developed that provide structural support and present a carefully defined set of biochemical and biophysical cues to cells. While biomaterials can guide cell behavior and promote desirable tissue regeneration outcomes, one remaining challenge in the field is inherent donor-to-donor variability in MSC behavior, phenotype, and differentiation capacity. Although MSCs are promising tools for regeneration, the influence of donor variability on MSC differentiation across culture models remains poorly understood. Previous studies typically use cells from a single donor or rely solely on standard culture models. To address these gaps, we compared MSCs from six human donors and assessed differentiation across chondrogenic, osteogenic, and adipogenic lineages using both standard (pellet or 2D) and 3D biomaterial-based culture models. Alginate hydrogels were used to assess chondrogenesis, while gelatin microribbon (µRB) hydrogels were used to evaluate osteogenesis and adipogenesis in 3D. Significant donor-to-donor variability was observed in differentiation outcomes across all three lineages and within both 2D and 3D culture models. By directly comparing donor variability in 2D and 3D, we provide evidence that standard 2D models cannot predict MSC differentiation capacity in 3D biomaterials. Therefore, to improve therapeutic efficacy and advance biomaterial-based strategies for tissue regeneration, it is critical to understand how donor variability affects MSC differentiation patterns across 3D biomaterial-based culture models.

Indexed as

Cell Culture TechniquesCell Culture Techniques, Three DimensionalCell DifferentiationMesenchymal Stem CellsTissue DonorsAdipogenesisAdultCells, CulturedChondrogenesisFemaleHumansHydrogelsMaleMiddle AgedOsteogenesisTissue ScaffoldsHydrogelsbiomaterialsculture modelsdifferentiationdonor variabilitymesenchymal stem cells

Identifiers

PMID40407303
PMCPMC13178311

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.